- Home
- ORGO vs RMR Comparison
ORGO vs RMR Comparison
Compare ORGO & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGO | RMR |
|---|---|---|
| Founded | 1985 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.6M | 307.0M |
| IPO Year | 2016 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ORGO | RMR |
|---|---|---|
| Price | $2.47 | $19.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $8.50 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 1.3M | 189.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.37% |
| EPS Growth | ★ 1600.00 | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | $564,169,000.00 | ★ $700,284,000.00 |
| Revenue This Year | N/A | $259.61 |
| Revenue Next Year | $26.27 | $2.45 |
| P/E Ratio | ★ N/A | $24.83 |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $2.04 | $14.26 |
| 52 Week High | $7.08 | $20.48 |
Technical Indicators
Market Signals| Indicator | ORGO | RMR |
|---|---|---|
| Relative Strength Index (RSI) | 49.77 | 64.07 |
| Support Level | $2.21 | $14.72 |
| Resistance Level | $2.63 | $20.48 |
| Average True Range (ATR) | 0.21 | 0.65 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 59.73 | 66.57 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company with a primary focus on commercial real estate and related businesses in the United States. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. The company manages a diverse portfolio of real estate assets across sectors such as office, industrial, healthcare, retail, and hospitality, etc. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company derives the majority of its revenues from its provision of management services.